new_0222_0711|ORPH|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0711|ORPH|1|Orphazyme AS Total Current Assets (Quarterly) (USD)|Orphazyme AS Cash and Short Term Investments (Quarterly) (USD)|Orphazyme AS Inventories (Quarterly) (USD)|Orphazyme AS Net PP&E (Quarterly) (USD)|Orphazyme AS Goodwill and Intangibles (Quarterly) (USD)|Orphazyme AS Total Liabilities (Quarterly) (USD)|Orphazyme AS Total Current Liabilities (Quarterly) (USD)|Orphazyme AS Total Long Term Liabilities (Quarterly) (USD)|Orphazyme AS Total Deposits (Quarterly) (USD)|Orphazyme AS Book Value (Quarterly) (USD)|Orphazyme AS Retained Earnings (Quarterly) (USD)|Orphazyme AS Treasury Stock (Quarterly) (USD)|Orphazyme AS EV to Revenues|Orphazyme AS EV to Earnings|Orphazyme AS EV to Free Cash Flow|Orphazyme AS EV to Assets (Quarterly)|Orphazyme AS PS Ratio|Orphazyme AS PE Ratio|Orphazyme AS Price to Book Value|Orphazyme AS PEG Ratio|Orphazyme AS Debt to Equity Ratio|Orphazyme AS Dividend Yield|Orphazyme AS Shareholder Yield (TTM)|Orphazyme AS Percent of Shares Outstanding Short|Orphazyme AS Total Receivables (Quarterly) (USD)|Orphazyme AS Total Payables (Quarterly) (USD)|Orphazyme AS Total Capital Stock (Quarterly) (USD)|Orphazyme AS Return on Invested Capital|Orphazyme AS Quality Ratio Score|Orphazyme AS Momentum Score|Orphazyme AS Beta (1Y)|Orphazyme AS Sustainable Growth Rate (TTM)|Orphazyme AS Institutional Investor Ownership Percentage|Orphazyme AS Average Diluted Shares Outstanding (Quarterly)|Orphazyme AS Total Employees (Annual)|Orphazyme AS EPS Diluted (Quarterly) (USD)|Orphazyme AS Shares Outstanding|Orphazyme AS Repurchase of Capital Stock (Quarterly) (USD)|Orphazyme AS Ordinary Shares Number (Quarterly)|Orphazyme AS Payout Ratio|Orphazyme AS Quick Ratio (Quarterly)|Orphazyme AS Normalized Diluted EPS (Quarterly) (USD)|Orphazyme AS Stock Buybacks (Quarterly) (USD)|Orphazyme AS Effective Tax Rate (TTM)|Orphazyme AS Return on Equity|Orphazyme AS Net Income (TTM) (USD)|Orphazyme AS Revenue (TTM) (USD)|Orphazyme AS Dividend Per Share (Quarterly) (USD)|Orphazyme AS Revenue (Quarterly) (USD)|Orphazyme AS Gross Profit (Quarterly) (USD)|Orphazyme AS SG&A Expense (Quarterly) (USD)|Orphazyme AS Pre-Tax Income (Quarterly) (USD)|Orphazyme AS Net Income (Quarterly) (USD)|Orphazyme AS Net Interest Income (Quarterly) (USD)|Orphazyme AS Price (USD)|Orphazyme AS Total Return Price (USD)|Orphazyme AS Enterprise Value (USD)|Orphazyme AS 30-Day Average Daily Volume|Orphazyme AS 1 Year Price Returns (Daily)||
new_0222_0711|ORPH|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0711|ORPH|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0711|ORPH|5|182.444444444|182.444444444|0|182.444444444|182.444444444|182.444444444|182.444444444|182.444444444|0|182.444444444|182.444444444|0|0|0|1.44571428571|0|0|0|1.44444444444|0|0|1.44571428571|0|15.25|182.444444444|182.444444444|182.444444444|0|0|30.6666666667|30.75|0|30.5|0|163.428571429|0|36.5833333333|0|182.444444444|0|0|0|0|182.444444444|0|182.444444444|0|0|0|0|0|0|0|0|1.44444444444|1.44444444444|1.44571428571|1.44859813084|1.4387755102||
new_0222_0711|ORPH|6|9|9|0|9|9|9|9|9|0|9|9|0|0|0|350|0|0|0|351|0|0|350|0|32|9|9|9|0|0|3|4|0|14|0|7|0|36|0|9|0|0|0|0|9|0|9|0|0|0|0|0|0|0|0|351|351|350|321|98||
new_0222_0711|ORPH|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0711|ORPH|201612|3.9668|2.0406||0.1404|0|2.0524|2.0524|0||2.49|-30.168||||||||||||||1.9262|2.0524|0.478||||||||||||19.9282|||||8.6777||-8.5899|||||||||||||||
new_0222_0711|ORPH|201706|21.345|5.167||0.1549||3.7558|3.7558|0||18.6591|-40.6511||||||||||||||15.6788|3.7558|0.785||||||||||||19.9282|||||6.3488||-12.0786|||||||||||||||
new_0222_0711|ORPH|201709|||||||||||||||||||||||||||||||||||21||19.9282||||||||||||||||||||||||
new_0222_0711|ORPH|201712|104.4176|101.8041||0.2983|1.5878|7.5926|7.5926|0||99.2204|-54.504||||||||||||||1.8324|2.1652|3.2114||||||||34||19.9282||19.9282|||||4.1481||-19.4289|||||||||||||||
new_0222_0711|ORPH|201806|81.8599|79.634||0.2895|1.4732|5.4807|5.4807|0||78.9631|-69.0321||||||||||||||2.226|5.4807|3.0931||||||||45||19.9396||19.9396|||||2.5398||-28.9958|||||||||||||||
new_0222_0711|ORPH|201812|64.8582|60.465||0.2972|1.6459|8.1344|8.1183|0.0161||59.4759|-86.5252||||||||||||||2.2128|2.7712|3.0545||||||||57||19.9396||19.9396|||||2.3298||-35.8939|||||||||||||||
new_0222_0711|ORPH|201903|||||||||||||||||||||||||||||||||||||19.9848||||||||||||||||||||||||
new_0222_0711|ORPH|201906|37.4826|34.3627||2.186|1.5996|8.2415|6.7694|1.4721||34.2506|-110.7658||||||||||||||3.1199|4.5254|3.0444||||||||72||19.9848||19.9848|||||2.0298||-43.2795|||||||||||||||
new_0222_0711|ORPH|201912|22.2222|18.5286||2.6368|1.58|19.1578|9.8931|9.2647||7.9412|-134.7826||||||||||||||1.6914|0.1639|2.996||||||||86||19.9848||19.9848|||||1.6028||-50.3931|||||||||||||||
new_0222_0711|ORPH|202003|||||||||||||||||||||||||||||||||||||27.0384||||||||||||||||||||||||
new_0222_0711|ORPH|202006|96.2742|92.0891||2.9853|1.6252|25.6793|18.375|7.3042||76.353|-171.7172||||||||||||||4.185|8.9659|4.0799||||||||114||27.0449||27.0449|||||1.1604||-62.8627|||||||||||||||
new_0222_0711|ORPH|202009|||||||||||||||-3.6303||||3.6639|||0||0|||||||||10.8771||||27.0816||||||||||||||||||10.33|10.33|197.738|40369.2||9.27|9.81
new_0222_0711|ORPH|202012|129.5279|120.1505||3.2307|2.0585|33.3823|27.5409|5.8413||102.5635|-248.4103||||-3.0925||||3.63|||0||0.0006|3.0502|5.6356|5.7351||||||0.5145||141||34.6977||34.6977|||||0.2861||-98.2934|||||||||10.73|10.73|261.6067|15444.1333||11.823|12.24
new_0222_0711|ORPH|202103|||||||||||||||-2.1559||||2.8575|||0||0.2062|||||||||0.8444||||34.9522||||||||||||||||||8.385|8.385|182.3746|88075.5667||9.4201|5.6
new_0222_0711|ORPH|202106|64.6037|53.4798||2.2289|0.3511|41.8113|35.7925|6.0188||26.6869|-312.6932||||-1.8154|3.079|||9.6264||0.2806|0||2.4983|11.1239|15.8589|5.5934||||||2.4537||||34.9522||34.9522||1.8049|||0.2671||-136.3255|||||||||7.35|7.35|210.9074|23228527.2||4.78|5.21
new_0222_0711|ORPH|202109|||||||||||||||-0.8406||||5.3829|||0||0.8655||||||1|1.5261||3.2733||||||||||||||||||||||4.11|4.11|97.6622|1412478.2|-60.213|3.89|3.24
new_0222_0711|ORPH|202112|||||||||||||||-0.3292||||3.1564|||0||0.943||||||1|0.9977||3.6903||||||||||||||||||||||2.41|2.41|38.2435|797571.6333|-77.5396|1.98|2.06